
Narayana Hrudaya Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Narayana Hrudaya management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Narayana Hrudaya management said on order book — free account, 30 seconds.
Capex plans
Track Narayana Hrudaya — get its next earnings analysis in your feed
How does Narayana Hrudaya rank vs peers in Healthcare Services?
Pro featureHow does Narayana Hrudaya rank in Healthcare Services?
Compare Narayana Hrudaya against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Narayana Hrudaya's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.